Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus
- 25 September 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 108 (2) , 703-718
Abstract
Background: As criteria for diagnosing Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) evolves, AD-related biological measures of biomarkers (e.g., amyloid, tau) and genetic status (e.g., APOE ) have gained heightened value in research, and, notably, increased personal significance for participants. Objective: To identify recommended approaches for sharing individual research results with participants in AD/ADRD research and determine expert consensus on best practices for sharing individual research results to participants in AD/ADRD research. Methods: This online, modified Delphi study consisted of four rounds of surveys conducted with Alzheimer's disease research experts, including neurologists, ethicists, neuropsychologists, geneticists, clinical trialists, and other research stakeholders. The Delphi survey was informed by a targeted literature review of previously published recommendations on sharing individual research results in AD/ADRD research. A total of 81 experts were surveyed across all rounds, ranking statements on a 7-point Likert scale and providing feedback in short answer responses. After each round, feedback reports were shared to inform subsequent responses. Proportion of agreement and qualitative feedback were analyzed, with consensus defined as 75% or greater agreement. Results: 41 initial statements were evaluated and refined based on consensus and feedback. Concluding the final round (round 3), consensus (≥75% agreement) was achieved on 25 statements, resulting in a set of recommendations related to: study design, clinical relevance, results sharing processes, communication and understanding of results, counseling and support, and follow-up. Conclusions: The findings of this online, modified Delphi study provide a foundation for developing standardized, ethically grounded practices for returning individual research results in Alzheimer's disease studies.Keywords
Funding Information
- Alzheimer's Association (AARG-22-974462)
This publication has 45 references indexed in Scilit:
- Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer DiseaseJAMA Network Open, 2025
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trialAlzheimer's & Dementia, 2022
- Reasons for undergoing amyloid imaging among cognitively unimpaired older adultsAnnals of Clinical and Translational Neurology, 2021
- Stakeholders’ Views on Early Diagnosis for Alzheimer’s Disease, Clinical Trial Participation and Amyloid PET Disclosure: A Focus Group StudyJournal of Bioethical Inquiry, 2019
- Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older AdultsJAMA Neurology, 2018
- Was it worth it? Patients’ perspectives on the perceived value of genomic-based individualized medicineJournal of Community Genetics, 2016
- Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research ResultsJAMA Neurology, 2015
- Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairmentInternational Journal of Geriatric Psychiatry, 2013
- The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)The Journal of nutrition, health and aging, 2009